Lexicon Pharmaceuticals
LXRX
#6705
Rank
A$1.17 B
Marketcap
A$2.65
Share price
-1.65%
Change (1 day)
18.55%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -A$89.98 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are A$41.46 Million. In 2025 the company made an earning of -A$74.52 Million, an increase over its 2024 earnings that were of -A$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$89.98 Million20.75%
2025 -A$74.52 Million-74.88%
2024 -A$0.3 Billion13.15%
2023 -A$0.27 Billion73.74%
2022 -A$0.16 Billion16.16%
2021 -A$0.13 Billion49.82%
2020 -A$86.7 Million-147.19%
2019 A$0.18 B-203.42%
2018 -A$0.18 Billion-15.31%
2017 -A$0.21 Billion0.2%
2016 -A$0.21 Billion2920.7%
2015 -A$6.93 Million-95.33%
2014 -A$0.15 Billion-3.61%
2013 -A$0.16 Billion-5.52%
2012 -A$0.17 Billion-4.17%
2011 -A$0.18 Billion15.5%
2010 -A$0.15 Billion8.36%
2009 -A$0.14 Billion-4.81%
2008 -A$0.15 Billion28.79%
2007 -A$0.12 Billion35.71%
2006 -A$81.75 Million52.91%
2005 -A$53.46 Million-23.89%
2004 -A$70.24 Million-24.19%
2003 -A$92.65 Million-0.48%
2002 -A$93.09 Million44.12%
2001 -A$64.6 Million23.01%
2000 -A$52.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
A$11.69 B-13,024.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.65 B-1,927.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$8.41 B-9,404.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-A$0.67 Billion 631.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$90.15 M-199.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.11 B-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$34.4 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$64.62 M-171.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$24.46 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA